Afghanistan's Health Minister will visit India around December 17th, the third high-level Afghan minister visit in months.
The order followed the company’s assurance that it would not market any anti-obesity products in India until the patent ...
The hospital lobby has filed a lawsuit seeking to block the federal government’s 340B Rebate Model Pilot Program, which is ...
Lawyer and human rights advocate Lorenzo “Erin” Tañada III welcomed the Professional Regulatory Commission (PRC) Board of ...
The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...
U.S. Bankruptcy Judge Sean Lane gave reasoning Tuesday for approving the plan, which requires members of the Sackler family who own the company to contribute up to $7 billion over 15 years. Most of ...
LONDON, Dec 11 (Reuters) - Hospitals in Britain are facing a "worst case scenario" from a wave of super flu, healthcare ...
We came across a bullish thesis on BioMarin Pharmaceutical Inc. on Value investing subreddit by BearWithMeGM. In this article ...
A proposed combination of Johnson & Johnson’s multiple myeloma bispecific Tecvayli has turned up positive trial data that ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for ...
27don MSN
Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval. A look at the details.
SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ -- Global plaintiffs' rights law firm Hagens Berman reminds investors of the December 8, 2025, deadline to move the Court for appointment as lead plaintiff in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results